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Lipooligosaccharide (LOS) is an integral component of the Campylobacter cell
membrane with a structure of core oligosaccharides forming inner and outer core
regions and a lipid A moiety. The gene content of the LOS core biosynthesis cluster
exhibits extensive sequence variation, which leads to the production of variable
cell surface LOS structures in Campylobacter. Some LOS outer core molecules in
Campylobacter jejuni are molecular mimics of host structures (such as neuronal
gangliosides) and are thought to trigger neuronal disorders (particularly Guillain–Barré
syndrome and Miller Fisher syndrome) in humans. The extensive genetic variation in
the LOS biosynthesis gene cluster, a majority of which occurs in the LOS outer core
biosynthesis gene content present between lgtF and waaV, has led to the development
of a classification system with 23 classes (A–W) and four groups (1–4) for the C. jejuni
LOS region. This review presents an updated and simplified classification system for
LOS typing alongside an overview of the frequency of C. jejuni LOS biosynthesis
genotypes and structures in various C. jejuni populations.
Keywords: lipooligosaccharide, Campylobacter jejuni, ganglioside mimics, Guillain–Barré syndrome, Miller Fisher
syndrome
INTRODUCTION
Campylobacter is a foodborne enteropathogen, which causes an acute, self-limiting gastroenteritis
in humans with various non-specific symptoms including watery or bloody diarrhea, abdominal
pain, headache, fever, chills, and dysentery (van Spreeuwel et al., 1985; Black et al., 1988; Perkins
and Newstead, 1994). The annual estimated number for Campylobacter infection is 96 million
worldwide (Havelaar et al., 2015). Campylobacter infection occurs in adults and children in
developing countries and can also lead to death in young children (Janssen et al., 2008). In some
cases, there can also be long-term, postinfection consequences of Campylobacter infection such as
the neuronal disorders Guillain–Barré syndrome (GBS) and Miller Fisher syndrome (MFS), Reiter’s
arthritis, and irritable bowel syndrome (IBS; Endtz et al., 2000; McCarthy and Giesecke, 2001).
Cohort studies on confirmed Campylobacter cases estimate that GBS develops following infection
in anywhere from 21 to 172 per 100,000 Campylobacter cases and that this rate is approximately
100-fold higher than in the general population (McCarthy and Giesecke, 2001; Tam et al., 2006;
Scallan Walter et al., 2019). Case–control studies on patients diagnosed with GBS repeatedly show
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a significant association with Campylobacter, with an average
rate of infection of 35.4% compared with 4.4% in controls
(Poropatich et al., 2010). A recent systematic review of all
factors contributing to the development of GBS concluded that
Campylobacter infection was the most common trigger of the
disease with a substantial evidence base (Wachira et al., 2019).
Campylobacter species, similar to Neisseria and Haemophilus,
lack lipopolysaccharide (LPS) in the outer-cell membrane and
instead possess lipooligosaccharide (LOS), which comprises of
lipid A and core structures (Mandrell et al., 1992; Moran, 1997;
Duncan et al., 2009). In comparison to LPS, LOS are low-
molecular weight biological molecules lacking O chains (Moran,
1997). Other Campylobacter cell-surface structures include
capsular polysaccharides (CPS), O-linked glycosylated flagellum,
and N-linked glycoproteins. LOS, CPS, and O-linked glycans
(mainly flagellar glycans) are variable among different strains,
while N-linked glycoproteins remain conserved (Szymanski et al.,
2003; Karlyshev et al., 2005; Day et al., 2012). The glycome
that comprises these four types of carbohydrate containing
conjugate molecules is synthesized by more than 8% of the
genome in Campylobacter jejuni 11168 (Parkhill et al., 2000;
Gundogdu et al., 2007).
No commercial vaccine has been developed for Campylobacter
to date, and this is largely due to the versatile and diverse
nature of Campylobacter physiology and genomics (Riddle and
Guerry, 2016). Subunit vaccines formed with flagellum-secreted
proteins (C. jejuni 81-176 FlaC, C. jejuni 81-176 FspA1, and
C. jejuni CG8486 FspA2) and recombinant protein (ACE 393)
have been experimentally tested in mice and healthy volunteers,
respectively, but no promising candidates for human vaccines
have been identified (Baqar et al., 2008; Poly et al., 2019).
Glycoconjugate vaccines such as C. jejuni 81–176 conjugated CPS
vaccine (CRM-197) has been tested in monkeys but remained
unsuccessful, as it did not provide adequate immunity (Monteiro
et al., 2009). A conjugated LOS vaccine has not been investigated
yet for C. jejuni; however, LOS of two C. jejuni strains BH-01-
0142 and CG8421 may be considered and utilized for vaccine
development (Poly et al., 2019). LOS functions as a virulence
determinant, immune modulator, and essential survival element,
which make it a potential glycoconjugate vaccine candidate.
However, prevalence of diverse LOS genotypes (due to variation
within the gene content of LOS biosynthesis gene cluster) and
presence of phase variation (a phenomenon where gene on/off
switching varies the cell-surface LOS structures and functions)
within the LOS biosynthesis genes are the two main features
that make LOS less desirable as a vaccine candidate (Guerry
et al., 2002; Gilbert et al., 2002; Parker et al., 2005, 2008).
Furthermore, it is unclear how LOS genotypes are reflected
in overall LOS biosynthetic structures. The prevalence of LOS
genotypes vary from geographic region to region, while phase
variation varies from strain to strain, and both types of LOS
locus variation need to be investigated for vaccine design. The
most prevalent LOS genotypes circulating regionally must be
taken into account for maximal efficiency of LOS-conjugated
vaccine, and therefore, the frequency of C. jejuni LOS genotypes
in different countries including United States, United Kingdom,
Netherlands, France, Belgium, Finland, Sweden, Japan, and
Bangladesh has been investigated previously (Godschalk et al.,
2004; Parker et al., 2005; Quiñones et al., 2007; Habib et al.,
2009; Ellström et al., 2013, 2014, 2016; Islam et al., 2014,
2018; Ohishi et al., 2017; Elhadidy et al., 2018; Thépault et al.,
2018). In this review, data from the literature relevant to
the distribution of C. jejuni LOS locus genotypes in various
geographical areas of the world will be analyzed to present an
up-to-date picture of C. jejuni LOS genotype predominance,
which may be important in vaccine design. This review also
presents an updated and simplified classification system for the
LOS biosynthesis locus to aid fellow researchers investigating
increasingly complex levels of LOS variation and the role it plays
in Campylobacter infection.
Campylobacter LOS AS A VIRULENCE
DETERMINANT
LOS in Campylobacter does not only maintain the integrity of
the cell membrane structure but also acts as a barrier for those
molecules, which are transported through the cell membrane
(Karlyshev et al., 2005). Deletion of LOS core in C. jejuni 11168
does not seem essential for viability (Marsden et al., 2009),
but truncation of LOS can be lethal in C. jejuni strains other
than 11168 (Phongsisay et al., 2007). For example, antibiotic
permeability into the cell increases due to alteration in LOS
structures, possibly because LOS structural changes decrease the
cell membrane hydrophobicity. This is the reason that mutants
of C. jejuni LOS genes are highly susceptible to some antibiotics,
specifically to erythromycin (Kanipes et al., 2004; Jeon et al.,
2009; Marsden et al., 2009). In addition to providing a barrier
to antibiotics, LOS also confers resistance to Campylobacter
cells against human serum proteins including α-defensins,
cathelicidins, and bactericidal-/permeability-increasing proteins
(Marsden et al., 2009; Keo et al., 2011). DNA uptake into
a bacterial cell is an outer cell membrane-dependent process.
Therefore, LOS modification in the outer cell membrane may
also affect Campylobacter’s ability to uptake foreign DNA or
its characteristic of natural transformation (Jeon et al., 2009;
Marsden et al., 2009). Mutants of Campylobacter LOS genes,
in comparison to their respective wild-type (WT) strains, have
showed reduced adherence and invasion into host intestinal
epithelial cells (Fry et al., 2000; Kanipes et al., 2004; Javed et al.,
2012), which might be due to reduced interaction between host
cell receptors and altered LOS structures. A caveat to these
studies is that deletion of LOS biosynthesis genes or drastic
changes in LOS structure may have a general destabilizing
effect on the LOS. A mutant of C. jejuni 11168, lacking
the core oligosaccharides in its LOS structures, was unable
to invade Caco-2 cells, indicating the importance of LOS in
Campylobacter invasion into host cells (Marsden et al., 2009).
C. jejuni strains with sialylated LOS showed higher potential
of adhesion, invasion, and translocation than those with non-
sialylated LOS (Louwen et al., 2012). Two sialic acid biosynthesis
genes (cgtB and wlaN) were found commonly present in highly
invasive C. jejuni strains (Müller et al., 2007), and mutation
of a sialic acid biosynthesis gene, cst-II, in a C. jejuni strain
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caused reduction in its invasion into epithelial cells (Louwen
et al., 2008), supporting the role of LOS sialylation or sialic
acid biosynthesis genes in C. jejuni invasion. However, C. jejuni
mutants of other LOS biosynthesis genes (waaC and cj1136) also
showed significant reduction in invasion into intestinal epithelial
cells (Kanipes et al., 2008; Javed et al., 2012). Furthermore,
only 23% of C. jejuni isolates from blood-borne infection or
truly invasive strains contained sialic acid biosynthesis genes
(Ellström et al., 2014). These studies indicate that not only sialic
acid biosynthesis genes but also the overall presentation of LOS
structure play an important role in adherence and invasion of
C. jejuni into host cells. Complete cell-surface LOS structures
in C. jejuni are also important for the optimum colonization of
chick ceca, and this is linked to the increased hydrophobicity
and susceptibility to bile of LOS mutants (Iwata et al., 2013).
Thus, LOS is an important virulence determinant in C. jejuni. It
may also be the case that since C. jejuni LOS are densely present
on the cell surfaces and they are readily available to stimulate
and interact with human immune cells such as macrophages,
LOS could also contribute to the binding of other cell types.
For example, the C. jejuni LOS terminal N-acetyl galactosamine
residues bind to the human macrophage galactose-type lectin
receptors (van Sorge et al., 2009). LOS containing sialic acid
residues have particular significance for human disease due
to their increased ability to bind to immune cells and their
similarity to neuronal structures. C. jejuni LOS sialic acid residues
bind to Toll-like receptor 4 (TLR-4) and sialoadhesin receptors
present on the human macrophage cell surfaces (Klaas et al.,
2012; Heikema et al., 2013; Stephenson et al., 2013). C. jejuni
LOS sialic acid residues are also ligands of sialic acid binding
immunoglobulin-like lectins present in human monocytes and
natural killer cells (Avril et al., 2006). The LOS structures with
variable epitopes presented on different C. jejuni cell surfaces
can also mimic human neuronal gangliosides. For this reason,
antibodies produced against the LOS structural epitopes do
not only bind to LOS structures but also to human neuronal
gangliosides. The cross-reactivity of anti-LOS antibodies with
human gangliosides leads to the development of neuronal
disorders (GBS and MFS) in humans (Yuki, 1997; Nachamkin
et al., 1998; Endtz et al., 2000; McCarthy and Giesecke, 2001;
Wakerley and Yuki, 2015). This is evident by the development
of pathological changes in peripheral nerves and weakness in
the limbs as well as production of anti-GM1 antibodies in
rabbits upon sensitization with C. jejuni LOS (Yuki et al.,
2004). Furthermore, knockout mutants of C. jejuni sialic acid
biosynthesis genes (orf10 and cst-II) with truncated and non-
sialylated LOS structures show reduced reactivity with GBS
patient serum. In addition, administration of these mutated LOS
structures into mice did not induce antiganglioside antibody
responses (Godschalk et al., 2004). The allelic variation in the
cst-II gene leads to the expression of either threonine (Thr)
or asparagine (Asn) at position 51 of the sialyltransferase
(Gilbert et al., 2002). This genetic polymorphism (and change
in host-mimicking ganglioside epitopes) can further affect the
development of autoimmune and clinical symptoms of GBS,
supporting the role of LOS gene variations in GBS (Koga et al.,
2005). In GBS, the cranial nerves extending from the brain
to various areas of the head and neck are affected, which
further develop difficulty in walking, muscle weakness, and
muscle pain, while MFS, a variant of GBS, is characterized
mainly by paralysis of eye muscles and problems with balance
and coordination (Nachamkin et al., 1998). These postinfection
complications are infrequent and typically appear in immune-
compromised individuals, such as individuals with HIV infection
(McCarthy and Giesecke, 2001; Janssen et al., 2008). They
do not develop solely as a consequence of Campylobacter
infection, and other bacterial or host-specific risk factors aid
in stimulating the production of antiganglioside antibodies
(Figure 1; Revez and Hänninen, 2012; Islam et al., 2014).
This varies among C. jejuni strains and Campylobacter-infected
individuals and contributes to a complex picture of GBS
development and progression postinfection (Godschalk et al.,
2007; Müller et al., 2007). Some C. jejuni strains do not produce
ganglioside mimicking LOS structures at all despite the presence
of sialic acid biosynthesis genes, and therefore, the presence
of sialylated LOS biosynthesis genes do not always correspond
with the C. jejuni potential for neural disease development
(Houliston et al., 2011).
THE LOS BIOSYNTHESIS LOCUS
IN C. jejuni
In proposing a new classification for the LOS, it is important to
appreciate the complexity of the LOS biosynthesis loci that has
informed rationale for current and historic classification systems.
The LOS lipid A backbone in C. jejuni contains a 3-diamino-2,3-
dideoxy-D-glucopyranose linked to 2-amino-2-deoxy-D-glucose
(GlcN), whereas the Campylobacter coli lipid A backbone consists
of two GlcN (Culebro et al., 2016). The lipid A backbone in
most of the Campylobacter strains is linked to six acyl chains
(two hydroxyl-linked and four amide-linked; Moran, 1997). The
LOS core biosynthesis in C. jejuni is achieved at the genetic level
by a cluster of LOS biosynthesis genes (Figure 2). Each LOS
biosynthesis gene produces an individual enzyme involved in
either monosaccharide biosynthesis or addition of a particular
monosaccharide to the LOS structure (Karlyshev et al., 2005;
Parker et al., 2005, 2008; Iwata et al., 2013). The inner core of
C. jejuni LOS has two heptose and two glucose units (Klena
et al., 1998; Gilbert et al., 2002; Kanipes et al., 2004, 2006). The
heptosyltransferase-I (waaC) adds the first heptose (Hep-I) to 3-
deoxy-D-manno-octulosonic acid (KDO). Heptosyltransferase-II
(waaF) catalyzes the addition of a second heptose (Hep-II) to
Hep-I (Klena et al., 1998; Kanipes et al., 2004, 2006). In C. jejuni
(strain 11168), Hep-1 and Hep-II are synthesized and added to
the inner core of LOS by the phosphoheptose isomerase (gmhA),
a D-glycero-beta-D-manno-heptose-7-phosphate kinase (waaE),
an ADP-L-glycero-D-manno-heptose-6-epimerase (waaD), and
a dephosphatase (gmhB; Karlyshev et al., 2005; Iwata et al.,
2013). Unlike the inner core, the outer core of LOS varies
extensively amongC. jejuni strains (Linton et al., 2000; Godschalk
et al., 2004; Houliston et al., 2011). The outer core of C. jejuni
11168 is synthesized by glycosyltransferases [cj1136 (orf4), cj1137
(orf14), and cj1138 (orf15)], N-acetyl galactosaminyl transferase
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FIGURE 1 | A summary of the different host–pathogen factors that contribute to the complexity of Guillain–Barré syndrome (GBS) development.
FIGURE 2 | A representation of C. jejuni 11168 lipooligosaccharide (LOS) core biosynthesis gene cluster and its LOS structure. Each arrow represents an individual
LOS core biosynthesis gene, and its direction indicates the direction of gene transcription. A LOS biosynthesis gene in yellow encodes an enzyme to catalyze the
addition of a KDO molecule to lipid A. LOS biosynthesis genes in light pink encode enzymes for the synthesis of LOS inner core structure. LOS biosynthesis genes in
green encode enzymes for the synthesis of LOS outer core structure, where LOS genes in light green (neuB1, neuC1, and cgtA/neuA1) synthesize sialic acid to
incorporate into the outer core. LOS genes in white (gmhA, waaE, waaD, and gmhB) synthesize heptoses for inner core. Glycan structures were drawn according to
the Symbol Nomenclature For Glycans (SNFG).
[cgtA/neuA1 (orf5/10)], sialyltransferase [cst-III (orf7)], and
galactosyltransferase (wlaN) and is illustrated as an example in
Figure 2 (Gilbert et al., 2000, 2002; Linton et al., 2000; Guerry
et al., 2002; Karlyshev et al., 2005; Javed et al., 2012). In addition
to core synthesis, a LOS biosynthesis gene (waaM) is located in
the cluster that encodes an enzyme (lipid A biosynthesis lauroyl
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acyltransferase) to catalyze the addition of a KDO molecule to the
backbone of lipid A (Karlyshev et al., 2005). Campylobacter LOS
structures are synthesized in the cytoplasmic side of the inner cell
membrane from where they are flipped to the periplasmic side of
the inner cell membrane and, finally, are integrated into the outer
cell membrane (Whitfield and Trent, 2014; Simpson et al., 2015).
Based on similarities to LPS assembly machinery in Escherichia
coli, it is predicted that N-linked glycosylation glycosyltransferase
(wlaM/pglG) and flippase (wlaB/pglK) can respectively facilitate
cytoplasm-to-periplasm LOS flipping and periplasm-to-outer cell
membrane LOS translocation in Campylobacter (Fry et al., 1998).
VARIATION IN C. jejuni LOS
BIOSYNTHESIS LOCUS
The variation in the C. jejuni LOS biosynthesis gene region
occurs either due to (i) mutations within the nucleotides of LOS
biosynthesis gene sequences or (ii) the recombination between
LOS biosynthesis gene/gene regions.
Variation at the Nucleotide Level
Nucleotide level variations within the LOS biosynthesis genes can
occur due to phase variation, where slip strand mispairing during
the replication of homopolymeric tracts can lead to insertions or
deletions of single bases (Gilbert et al., 2002). The LOS gene wlaN
in C. jejuni 11168, C. jejuni 331, and C. jejuni 2500 containing
a homopolymeric tract of 8G produces the fully transcribed and
functional gene product β-1,3-galactosyltransferase (Linton et al.,
2000; Müller et al., 2007; Semchenko et al., 2012). A variant
in these strains containing a 9G homopolymeric tract in wlaN
results in a frameshift mutation and premature translational
termination with a non-functional gene product, which cannot
add the terminal galactose in the LOS structure and consequently
converts a GM1-like LOS epitope into a GM2 mimic (Linton
et al., 2000; Semchenko et al., 2012). Site-directed mutagenesis
of the homopolymeric tract in C. jejuni 11168 wlaN from 8G
to 11G increases the rate of phase variation ∼10-fold in this
gene, and in general, the rate of phase variation increases with
longer tract lengths in multiple genes (Bayliss et al., 2012). Phase
variation of C. jejuni 11168 wlaN was not observed in vivo during
colonization of chickens aged 2–4 weeks, but an increase in
tract length from 8G to 9G to switch off expression of wlaN
was detected after the passage of C. jejuni 224 and 331 in 5-
day-old chicks, with C. jejuni 11168-O remaining unchanged
(Bayliss et al., 2012; Semchenko et al., 2012). In the same study,
C. jejuni 331 switched off wlaN after coculture with the intestinal
cell line CaCo-2 and C. jejuni 224 switched off expression of
the LOS genes Cj1144-45 after colonizing chicks, giving further
evidence that strain- and host-specific factors can both influence
phase variation of LOS genes (Semchenko et al., 2012). Phase
variation in a number of other LOS biosynthesis genes has been
observed at both the genotype and phenotype level in multiple
strains including cst-II, cgtA, cgtD, orf23, and orf25 (Guerry et al.,
2002; Parker et al., 2005; Godschalk et al., 2006, Godschalk et al.,
2007; Houliston et al., 2011; Wanford et al., 2018). Multiple
combinations of phase variable genes can also lead to novel
LOS structures. Different combinations of on and off phenotypes
in C. jejuni (strain GC149) are encoded by the cgtA and cgtD
outer core glycosyltransferases and result in structural molecular
mimics of either GD3 (cgtA off), GT1a (cgtA on/cgtD off),
or ganglio/Pk (cgtA on/cgtD on) gangliosides (Houliston et al.,
2011). Phase variation of LOS genes can therefore lead to mixed
populations of LOS gene variants and increase the diversity of
LOS structural epitopes within a single strain of Campylobacter
(Guerry et al., 2002).
Sequence variation may also occur due to single nucleotide
mutations, which can inactivate the LOS biosynthesis genes
without involving the phenomenon of phase variation. For
example, deletion of an A-base at position 1234 in lgtF (a LOS
biosynthesis gene) alters the catalytic activity of its encoded
enzyme, glycosyltransferase, in four C. jejuni strains (ATCC
43432, ATCC 43446, OH4382, and OH4384). As a result, the
produced glycosyltransferase does not have the potential to
catalyze the addition of ß-1,2-glucose to heptose-II during the
LOS synthesis. Similarly, the base substitution of the final base
in orf5/10 (cgtA/neuA1) in C. jejuni ATCC 43430 changes
the amino acid (cysteine → tyrosine), which further leads
to the production of a non-functional enzyme (Gilbert et al.,
2002). The LOS gene, cgtA, with missing A-base at position
71 substitutes one amino acid in the cgtA-encoding enzyme,
N-acetyl galactosaminyl transferase, which further leads to the
inactivation of N-acetyl galactosaminyl transferase in C. jejuni
OH4382 and OH4384 and truncates the LOS structure (Gilbert
et al., 2002). Similarly, a five-base deletion from the cst-III gene
of C. jejuni GB1 alters the number of amino acids (294→219)
in sialyltransferase and eventually produces a non-sialylated LOS
(Godschalk et al., 2007).
Variation at Allele or Gene Level and LOS
Locus Classes in C. jejuni
In recent years, an alphabetical system of class organization for
LOS genes within the C. jejuni LOS biosynthesis locus has been
developed based on 23 C. jejuni LOS classes (A through W),
which have been previously described (Gilbert et al., 2002; Parker
et al., 2008; Richards et al., 2013). An insertion or deletion of
a LOS biosynthesis gene or gene regions into the LOS locus
can give rise to a different class type (Parker et al., 2005, 2008).
Alterations of portions of the LOS biosynthesis genes or different
alleles can also establish a new class or subclass; for example, allele
variation in cgtA and wlaN genes generates A and B subclasses
including A1, A2, B1, and B2 (Parker et al., 2005). In addition,
disruption in resident LOS biosynthesis genes can also form a
new class; for instance, disruption in class E orf26 establishes the
LOS locus class P (Parker et al., 2005). The developed new locus
type can be variable both in gene content and gene organization
(Parker et al., 2005; Revez and Hänninen, 2012). C. jejuni acquires
new genes in its LOS biosynthesis region by horizontal gene
transfer. The horizontal transfer of LOS biosynthesis genes from
C. jejuni O4 (GM1 strain) to C. jejuni 81116 (non-GM1 strain)
changed it into a GM1-like LOS-producing strain (Phongsisay
et al., 2006). Similarly, a C. jejuni GB11 strain possessing class
C locus acquired a class A locus, identical to the LOS locus of
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C. jejuni ATCC 43446 while retaining the same sequence in the
remainder of the genome (Gilbert et al., 2004).
Variation in LOS biosynthesis gene alleles causes alterations
in the LOS structure. For instance, two cst-II gene alleles lead
to the expression of either threonine (Thr) or asparagine (Asn)
at position 51 of the translated enzyme. As a result, the enzyme
retains either a monofunctional (Thr → 2,3-sialyltransferase
activity) or a bifunctional (Asn→ 2,3- and 2,8-sialyltransferase)
activity and produces LOS with one and two sialic acids,
respectively (Gilbert et al., 2002). Variation in LOS locus gene
content can vary the carbohydrate content, linkages between the
carbohydrate units, and core length in cell-surface LOS structures
(Gilbert et al., 2002; Guerry et al., 2002). Variation in LOS locus
gene content as well as in its gene organization varies the cell-
surface LOS structurally and functionally. It is not always the
case that LOS structures belonging to the same LOS locus type
encode similar epitopes. C. jejuni 11168 and 520, both belong
to class C, but C. jejuni 520 can produce a wider variety of
human ganglioside mimics than C. jejuni 11168 (Semchenko
et al., 2012). C. jejuni strains that contain a type A LOS locus
frequently encode and express human ganglioside mimics on
bacterial cell surfaces, which include GM1a, GM1b, GD1a, and
GD1b (Nachamkin et al., 2002; Godschalk et al., 2004; Mortensen
et al., 2009). For example, there is a GM1-like mimic in C. jejuni
11168 (class C), a GQ1b-like mimic in C. jejuni 81-176 (Class B),
a Lewis type I-like mimic in C. jejuni RM1503 (class M), and
a paragloboside/Pk-like antigens in C. jejuni RM1221 (class F;
Godschalk et al., 2004; Mortensen et al., 2009; Houliston et al.,
2011). C. jejuni GC149 (class R) contains sialic acid biosynthesis
genes and may present ganglioside-like mimics (GT1a, GD3) as
well as a hybrid form of ganglio and P-type antigens (Parker
et al., 2008; Houliston et al., 2011). Other LOS classes such as
D and E also possess human ganglioside-like LOS structures,
but these are different to GM1, GD1, and GQ1b (Godschalk
et al., 2004). Class P LOS have a lack of sialic acid and possess
N-acetyl quinovosamine instead (Poly et al., 2008). The variable
LOS structural epitopes presented by different C. jejuni LOS locus
types are demonstrated in Table 1.
The expression of variable cell surface LOS structures and
mimicry with human blood antigen glycosphingolipids or
neuronal ganglioside glycosphingolipids as a consequence of gene
variation in the LOS locus in C. jejuni is an important virulence
factor and may have a direct link to the progression of specific
neuronal disorders postinfection (Ang et al., 2002; Müller et al.,
TABLE 1 | Variable lipooligosaccharide (LOS) structures synthesized by different C. jejuni LOS locus types.
LOS locus class (reference strain
and accession no.)
LOS structural epitopes Mimicry (reference)
A (RM1048/ATCC43432 AF215659) Human ganglioside glycosphingolipid (Nachamkin et al.,
2002; Godschalk et al., 2004; Mortensen et al., 2009)
B (81-176 CP000538.1) Human ganglioside glycosphingolipid (Godschalk et al.,
2004; Mortensen et al., 2009)
C (11168 AL111168.1) Human ganglioside glycosphingolipid (Linton et al., 2000)
D (RM3418 EU404109) Human ganglioside-like LOS structures other than GM1,
GD1, and GQ1b (unknown)
Unknown (Godschalk et al., 2004)
E (81116 CP000814) Human ganglioside-like LOS structures other than GM1,
GD1, and GQ1b (unknown)
Unknown (Godschalk et al., 2004)
F (RM1221 CP000025) P1 blood group glycosphingolipid Partial P1 blood group
glycosphingolipid Partial human ganglioside
glycosphingolipid (Houliston et al., 2011)
M (RM1503 EF140720) Lewis type-1 glycosphingolipid (Houliston et al., 2011)
P (4031 HG428754.1) Non-sialylated LOS with N-acetyl quinovosamine No mimics (Poly et al., 2008)
R (GC149 AY962325) Human ganglioside glycosphingolipid Partial P1 blood
group glycosphingolipid Partial human ganglioside
glycosphingolipid (Houliston et al., 2011)
Experimentally characterized LOS structures to date. Hypothetical structures are not included here. Glycans in LOS structures were drawn according to the Symbol
Nomenclature For Glycans (SNFG).
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2007; Houliston et al., 2011; Semchenko et al., 2012). For example,
C. jejuni strains with LOS locus class A and variable human
ganglioside mimics (GM1a, GM1b, GD1a, and GD1b) trigger
GBS in Campylobacter-infected patients (Nachamkin et al., 2002;
Godschalk et al., 2004, 2007; Mortensen et al., 2009), whereas
C. jejuni strains with LOS class B and corresponding GQ1b-like
LOS structures are likely to develop MFS in Campylobacter-
infected patients (Godschalk et al., 2007; Islam et al., 2014).
Genetic diversity within the LOS locus plays an important role
in the development of postinfection effects; however, this does
not have any association with acute-phase symptoms such as
diarrhea or abdominal pain (Poly et al., 2008; Mortensen et al.,
2009; Ellström et al., 2013). This indicates that LOS sialylation
is not required for human diarrheal disease and that both the
sialylated and non-sialylated LOS can be used for vaccine design
(Poly et al., 2008, 2019).
SIMPLIFICATION OF C. jejuni LOS
LOCUS CLASSIFICATION
LOS classes A–H were initially described (Gilbert et al., 2002;
Parker et al., 2005), and these known C. jejuni LOS classes were
then primarily categorized into four groups and included LOS
classes A, B, and C belonging to a group 1, LOS class E in group
2, LOS classes D and F in group 3, and LOS class G in group 4
(Karlyshev et al., 2005). Later, Parker et al. (2008) identified 11
more C. jejuni LOS classes including I–S. Subsequently, Richards
et al. (2013) identified C. jejuni strains with novel LOS loci and
established four more LOS classes including T, U, V, and W. The
novel LOS loci identified in the latter two studies have never been
assigned to the LOS groups. To better understand the prevalence
of C. jejuni LOS groups and groups related to LOS classes, we
propose a simplified LOS classification system (Figure 3) where
various already known LOS classes have been assigned into the
pre-established LOS groups (Karlyshev et al., 2005) on the basis of
sharing similar LOS biosynthesis gene content. Group 1 includes
all the LOS locus types (A, B, C, R, M, and V), which contain
genes for sialic acid synthesis and translocation (orf7/cst-II/cst-
III, orf8/neuB1, orf9/neuC1, and orf10/neuA1), whereas the other
three groups have LOS loci with no sialic acid biosynthesis genes.
Based on sequence similarity of LOS loci H, O, P, and W to locus
E (orf21–orf34), these four classes are now assigned to group
2. Furthermore, K, Q, N, I, J, and S sharing orf17, orf18/cgtH,
orf19/cgtG, and orf20/cgtE are assigned to LOS group 3, and L,
G, T, and U sharing orf36, orf37, and orf38 are assigned to LOS
group 4 classes.
PREVALENCE OF C. jejuni LOS LOCUS
CLASSES AND GROUPS
A large number of available C. jejuni genomes with metadata have
been deposited in recent years and have the potential to provide
a full and comprehensive overview of the frequency of C. jejuni
LOS genotypes in C. jejuni populations (from different isolation
sources and various clonal complexes). However, much of these
data remain unpublished and should be a focus of ongoing efforts.
However, analysis of previously published studies examining the
frequencies of C. jejuni LOS locus classes and groups present
in enteritis, GBS, blood borne infection, and poultry-associated
C. jejuni populations indicates that the hierarchy of LOS group
(group 1 > group 2 > group 3 > group 4) is largely conserved
among human- and poultry-derived C. jejuni isolates (Figure 4).
This also indicates that the B and C LOS classes in clinical enteric
disease and LOS class A in GBS-associated C. jejuni populations
are found to be highly predominant. In comparison to the high
prevalence of LOS class C (42%) in clinical isolates in Sweden
FIGURE 3 | Simplified C. jejuni lipooligosaccharide (LOS) locus classification system. LOS classes are classified into the previously established four groups on the
basis of sharing similar LOS biosynthesis gene content. Arrows in checked boxes: LOS biosynthesis gene content, shared between the classes within a LOS group;
Blue arrows: Variable LOS biosynthesis genes, located between lgtF (orf3) and waaV (orf12); pink arrows: LOS biosynthesis genes, commonly present in all LOS
classes. Genes are numbered according to the Parker et al. (2005) numbering system. Arrow direction represents the direction of gene transcription.
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FIGURE 4 | A comparison of previous findings of distribution of C. jejuni lipooligosaccharide (LOS) locus genotypes in various C. jejuni populations. ENT, C. jejuni
isolates from enteritis patients; GBS, C. jejuni isolates from GBS patients; chick, C. jejuni isolates from chicken; BB infection, C. jejuni isolates from patients with
blood-borne infections.
(Ellström et al., 2016), a very small number of clinical strains (2%)
in Bangladesh had association with LOS locus C (Islam et al.,
2018), suggesting that C. jejuni LOS class distribution may vary
geographically. Furthermore, when comparing the combined
frequency of LOS ABC types in different populations of C. jejuni
isolates (clinical, enteritis, and poultry), approximately 50–75%
of strains in all C. jejuni populations belong to LOS classes A,
B, or C. The only exception to these results was the data from
Ellström et al. (2014) where C. jejuni were isolated from human
blood-borne infections.
A definite correlation between C. jejuni LOS locus class
prevalence and sequence type (ST) distribution has not been
established yet due to the diverse population structure of C. jejuni
(Habib et al., 2009; Islam et al., 2014). A few studies have
shown concordance between specific STs and LOS classes. For
example, LOS class B possessing GBS (50%) and enteritis (25%)
C. jejuni isolates had ST-403 CC (Islam et al., 2009). Another
study assigned class B diarrheal C. jejuni strains (3%) with ST-206
CC (Habib et al., 2009). LOS class C was associated with ST-21 CC
in 14% of C. jejuni enteritis isolates (Revez and Hänninen, 2012),
11.2% of C. jejuni bacteremia isolates (Ellström et al., 2013), and
3.2% of diarrheal C. jejuni isolates (Habib et al., 2009). High
frequency of LOS locus class C may be a contributor to the high
predominance of clinical C. jejuni strains with ST-21 CC (Habib
et al., 2009; Thépault et al., 2018). This ST-21 CC has also been
found in LOS class A positive bacteremia (2.8%) and diarrheal
C. jejuni (0.4%) isolates (Habib et al., 2009; Ellström et al., 2013;
Ohishi et al., 2017), which might be due to the close phylogenetic
relationship between C. jejuni isolates with LOS classes A and C
(Gilbert et al., 2008). LOS group 2 classes (E, H, O, and P) are
associated with ST-677 CC and ST-45 CC in C. jejuni bacteremia
isolates (Ellström et al., 2013). However, another study found two
other STs (ST-353 CC and ST-443 CC) for LOS group 2-related
diarrheal C. jejuni strains in addition to ST-45 CC (Habib et al.,
2009). Group 3 LOS class D have diarrheal C. jejuni strains (5%)
that were assigned with ST-354 CC (Habib et al., 2009).
CONCLUDING REMARKS
This review extends the C. jejuni LOS locus classification system.
Currently, genomic-based classification of the LOS region is
incomplete and vague. By providing a more refined classification
system, investigators will be more readily able to link genomic
class to LOS biosynthetic structures as they become available.
Full LOS structural characterization is currently limited, so it is
hard to determine whether locus classes will readily align with
LOS structures and is clearly a focus for future research and
may aid vaccine design. We also provide an overview of the
frequency of C. jejuni LOS genotypes in C. jejuni populations
originated from different sources and reviews the association
between C. jejuni LOS locus genotypes and different human
ganglioside-mimicking sialylated LOS structures. This review
summarizes the various contributing factors in GBS development
post-Campylobacter infection and shows that LOS group 1
containing LOS locus classes A, B, and C are commonly present
in almost every type of C. jejuni population studied to date,
regardless of its originating source.
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